21/02/2017
Auris Medical Announces Closing of $10 Million Public Offering
Auris Medical Holding AG(NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced the closing of its previously announced public offering [...]
